DE69513027D1 - Verfahren zur bestimmung des präthrombotischen status - Google Patents

Verfahren zur bestimmung des präthrombotischen status

Info

Publication number
DE69513027D1
DE69513027D1 DE69513027T DE69513027T DE69513027D1 DE 69513027 D1 DE69513027 D1 DE 69513027D1 DE 69513027 T DE69513027 T DE 69513027T DE 69513027 T DE69513027 T DE 69513027T DE 69513027 D1 DE69513027 D1 DE 69513027D1
Authority
DE
Germany
Prior art keywords
determining
prehrombotic
status
amount
relates
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69513027T
Other languages
English (en)
Other versions
DE69513027T2 (de
Inventor
Jean-Marie Freyssinet
Benedicte Antoni
Frederic Donie
Helmut Lill
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Freyssinet SAS
Original Assignee
Roche Diagnostics GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roche Diagnostics GmbH filed Critical Roche Diagnostics GmbH
Publication of DE69513027D1 publication Critical patent/DE69513027D1/de
Application granted granted Critical
Publication of DE69513027T2 publication Critical patent/DE69513027T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56966Animal cells
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/86Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/92Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701Details
    • G01N2333/4718Lipocortins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Zoology (AREA)
  • Virology (AREA)
  • Biophysics (AREA)
  • Endocrinology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DE69513027T 1994-07-23 1995-07-19 Verfahren zur bestimmung des präthrombotischen status Expired - Lifetime DE69513027T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP94111514 1994-07-23
PCT/EP1995/002846 WO1996003655A1 (en) 1994-07-23 1995-07-19 Method for the determination of the prethrombotic state

Publications (2)

Publication Number Publication Date
DE69513027D1 true DE69513027D1 (de) 1999-12-02
DE69513027T2 DE69513027T2 (de) 2000-03-16

Family

ID=8216140

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69513027T Expired - Lifetime DE69513027T2 (de) 1994-07-23 1995-07-19 Verfahren zur bestimmung des präthrombotischen status

Country Status (7)

Country Link
US (1) US7005271B1 (de)
EP (1) EP0772778B1 (de)
JP (1) JP3574659B2 (de)
AT (1) ATE186121T1 (de)
DE (1) DE69513027T2 (de)
ES (1) ES2139957T3 (de)
WO (1) WO1996003655A1 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6284475B1 (en) * 1997-07-11 2001-09-04 Mount Sinai School Of Medicine Of The City Of New York Assays for diagnosis of thrombophilic disease
US7687272B1 (en) 1998-01-12 2010-03-30 Henry Buchwald Method and apparatus for determining blood oxygen transport
CA2348612A1 (en) * 1998-10-23 2000-05-04 Barry S. Coller Method for determining platelet count
US6806091B1 (en) 1999-01-12 2004-10-19 Henry Buchwald Method and apparatus for determining blood oxygen transport
CN1250567C (zh) * 2000-07-21 2006-04-12 财团法人化学及血清疗法研究所 钙离子结合蛋白的提纯方法
US7645739B2 (en) 2001-02-21 2010-01-12 Alavita Pharmaceuticals, Inc. Modified annexin compositions and methods of using same
US7635676B2 (en) 2001-02-21 2009-12-22 Alavita Pharmaccuticals, Inc. Modified annexin proteins and methods for their use in organ transplantation
EP1839670A3 (de) 2001-02-21 2009-11-11 Alavita Pharmaceuticals, Inc. Modifizierte Annexinproteine und deren Verwendung zur Thrombosetherapie
US7635680B2 (en) 2001-02-21 2009-12-22 Alavita Pharmaceuticals, Inc. Attenuation of reperfusion injury
US6746872B2 (en) 2002-01-16 2004-06-08 Lifescan, Inc. Control compositions and methods of use for coagulation tests
US20070243632A1 (en) 2003-07-08 2007-10-18 Coller Barry S Methods for measuring platelet reactivity of patients that have received drug eluting stents
US7790362B2 (en) 2003-07-08 2010-09-07 Accumetrics, Inc. Controlled platelet activation to monitor therapy of ADP antagonists
WO2007086069A1 (en) * 2006-01-27 2007-08-02 Rappaport Family Institute For Research In The Medical Sciences Methods and kits for determining blood coagulation
FR2917172B1 (fr) * 2007-06-07 2014-01-03 Inst Nat Sante Rech Med Methode de mesure de l'activite plasmine des microparticules presentes dans un echantillon de fluide biologique et utilisation
US20100255514A1 (en) 2007-08-16 2010-10-07 The Royal Institution For The Advancement Of Learning/Mcgill University Tumor cell-derived microvesicles
JP5769417B2 (ja) 2007-08-16 2015-08-26 ザ ロイヤル インスティチューション フォー ザ アドバンスメント オブ ラーニング/マギル ユニバーシティ 腫瘍細胞由来微小胞
EP2598652A4 (de) 2010-07-29 2014-04-30 Shire Human Genetic Therapies Tests zum nachweis von glykosaminoglykanen
WO2013116677A2 (en) * 2012-02-01 2013-08-08 Shire Human Genetic Therapies, Inc. Assays for detection of glycosaminoglycans

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4668638A (en) 1983-03-24 1987-05-26 The Liposome Company, Inc. Liposome composition for lupus assay
FR2621128B1 (fr) 1987-09-30 1994-05-06 Sanofi Trousse et methode de dosage immunometrique applicables a des cellules entieres
US5340719A (en) 1990-11-23 1994-08-23 Corporation Coulter Method and apparatus for optically screening microscopic cells
US5266462A (en) * 1992-06-03 1993-11-30 Baxter Diagnostics Inc. Measurement of platelet activities
CA2072548A1 (en) 1992-06-26 1993-12-27 Michael W. Stewart Methods for determining antiphospholipid antibodies
DE4229933A1 (de) * 1992-09-08 1994-03-10 Max Planck Gesellschaft Verfahren zur Bestimmung von Thrombose verursachenden Lupus-anticoagulant-Antikörpern
US5472852A (en) * 1993-09-15 1995-12-05 Oklahoma Medical Research Foundation Assay for detection of selective Protein C inhibition by patients

Also Published As

Publication number Publication date
EP0772778A1 (de) 1997-05-14
EP0772778B1 (de) 1999-10-27
JP3574659B2 (ja) 2004-10-06
ATE186121T1 (de) 1999-11-15
US7005271B1 (en) 2006-02-28
WO1996003655A1 (en) 1996-02-08
ES2139957T3 (es) 2000-02-16
JPH10503023A (ja) 1998-03-17
DE69513027T2 (de) 2000-03-16

Similar Documents

Publication Publication Date Title
DE69513027D1 (de) Verfahren zur bestimmung des präthrombotischen status
TR199801390T2 (xx) Tromboz tedavisinde kullan�lacak p�ht�la�may� �nleyici maddeler
DE69010893D1 (de) Verfahren zur behandlung von koks sowie löschen desselben.
FI843496A (fi) Anordning foer att finna tvaergaoende borrhaol i implantat i benmaergen.
DE69535448D1 (de) Vorrichtung zur Unterdrückung von stimulierter Brillouin Streuung
ATE163195T1 (de) Lösliche liganden für cd40
DE69711034D1 (de) Wässrige fluorpolymerlösungen zur behandlung von harten oberflächen
DE60126795D1 (de) Verfahren und Kit zur Bestimmung der geographischen bzw. populationsmässigen Herkunft von Menschen
ATE255420T1 (de) Verwendung von tumorzellen zeitversetzt in kombination mit intakten antikörpern zur immunisierung
DE3486081D1 (de) Verfahren und testzusammensetzung zur bestimmung von wasserstoffperoxid.
DE69630955D1 (de) Immortalisierung bzw. desimmortalisierung von zellen
ATE127853T1 (de) Verfahren zur bestimmung der funktionellen wirkung von freiem protein s oder protein c in einer plasmaprobe.
IT8421788A0 (it) Composizione e metodo di pulitura.
DE59804931D1 (de) Verfahren zur selektiven hydrierung von ethylenisch ungesättigten doppelbindungen in polymerisaten
DE69001248D1 (de) Verfahren und zusammensetzungen zur isolation von menschlichem relaxin.
DE3586831D1 (de) Verfahren zur behandlung des bodens und zusammensetzung zur konservierung von stickstoff im boden.
DE69525226D1 (de) Vorrichtung und Verfahren zur Bestimmung von Wasserstoffperoxid
DE3585238D1 (de) Verfahren zur bestimmung des reduzierten zustands von nicotinamid-adenin-dinukleotid.
TR199801988T2 (xx) Kalp yetmezli�inin endotelin antagonistleri ile tedavisi i�in y�ntem.
DE3678621D1 (de) Verfahren und testzusammensetzung zur bestimmung von wasserstoffperoxyd.
DE59105482D1 (de) Verfahren und Mittel zur kolorimetrischen Bestimmung von Nitrationen.
DE3586371D1 (de) Verfahren zur behandlung des bodens und zusammensetzung zur konservierung von stickstoff im boden.
IT8420757A0 (it) Metodi e composizioni di fumigazione.
IT8447751A0 (it) Composizione contenente polisaccaride per legare proteine specifiche, metodo per ottenerla e procedimento nonche' corredo di saggio che la impiegano
DE69627655D1 (de) Schneidelement, stopfen und verfahren zur verhinderung des eindringens von spül-schlamm in das schneidelement

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: FREYSSINET, JEAN MARIE, DR., STRASSBURG/STRASBOURG

8328 Change in the person/name/address of the agent

Free format text: WEICKMANN & WEICKMANN, 81679 MUENCHEN